HR Execs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Protime Sports Inc.

Protime Sports was founded in 2007 as a factory direct supplier located in Seattle Washington. With the exception of licensed product, all uniform items sold are Protime Sports apparel which provides the purchaser with the best possible pricing. Our own manufacturing facility allows us complete product quality and control. Printing, decoration, sublimation and embroidery are done in house to assure absolute order accuracy and quick turn times. Large levels of inventory are maintained in our 55,000 square foot facility to accommodate "at once" orders during the peak of the season. Our on-site cutting and sewing operation allow for quick fill-ins when product is running low on popular styles. We ship nationwide to baseball, soccer, basketball and volleyball clubs and organizations. We offer customers a wide range of tools to help make the ordering process as simple and clear as possible. Protime Sports will supply clubs with size samples, pre-order checklists, product samples and mock-up as well as an impressive spirit wear program. We strive to offer flexibility and diversity to meet your needs and expectations. Through honesty and integrity, our goal remains to deliver premier quality uniforms on time, with the best customer service in the industry.

ABB

ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The companys solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on over 140 years of excellence, ABBs more than 105,000 employees are committed to driving innovations that accelerate industrial transformation. www.abb.com Privacy notice & house rules: https://social.abb/social-media-information Before applying for a job at ABB, please read our Fraud Warning: https://careers.abb/global/en/fraud-warning

BIG3

The BIG3 is the premier league for 3v3 hoops. Featuring many of the worlds most popular and accomplished athletes.

MAP

We are a Performance Improvement Consulting Firm Increase profitability and productivity with our proven Management System™. It is an accountability system that creates focus and alignment driving breakthrough results for your business. WHY WORK WITH US? 1. RESULTS Over 15,000 organizations and 170,000 business leaders accelerated their leadership and management performance through our proven MAP Management System™. 2. EXPERIENCE Our consultants are former CEOs and entrepreneurs with a track record of success who work with you every step of the way on business strategy and implementation. 3. LONGEVITY Weve been around since 1960 and worked on an incredibly diverse range of challenges across all industries and sizes. Are you ready to take your business to the next level?

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.